| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CALADRIUS BIOSCIENCES, INC. | CLO, SVP of Corp Dev | Common Stock | 160,827 | $480,873 | $2.99 | 14 Jan 2022 | Direct |
| PROKIDNEY CORP. | Chief Legal Officer | Class B Ordinary Shares | 163,857 | $462,126 | $2.82 | 31 Jul 2024 | Direct |
| PROKIDNEY CORP. | Chief Legal Officer | Common Units in ProKidney LP | 163,857 | $462,126 | $2.82 | 31 Jul 2024 | Direct |
| PROKIDNEY CORP. | Chief Legal Officer | Class A Ordinary Shares | 163,856 | $409,640 | $2.50 | 31 Jul 2024 | Direct |
| Longeveron Inc. | Director | Common stock | 5,000 | $6,545 | $1.31 | 25 Feb 2022 | Direct |
| PROKIDNEY CORP. | Chief Legal Officer | Employee stock option (right to buy) | 650,000 | 01 Mar 2025 | Direct | ||
| PROKIDNEY CORP. | Chief Legal Officer | Employee stock option (right to buy) | 234,742 | 01 Mar 2024 | Direct | ||
| CALADRIUS BIOSCIENCES, INC. | CLO, SVP of Corp Dev | Stock Option (Right to Buy) | 65,000 | 10 Jan 2022 | Direct | ||
| Longeveron Inc. | Director | Stock Option (Right to buy) | 5,000 | 21 Dec 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PROK | PROKIDNEY CORP. | 01 Mar 2025 | 1 | $0 | 4 | Chief Legal Officer | 04 Mar 2025, 16:41 |
| PROK | PROKIDNEY CORP. | 31 Jul 2024 | 3 | $0 | 4 | Chief Legal Officer | 02 Aug 2024, 16:03 |
| PROK | PROKIDNEY CORP. | 01 Mar 2024 | 2 | $0 | 4 | Chief Legal Officer | 05 Mar 2024, 16:12 |
| PROK | PROKIDNEY CORP. | 05 Feb 2024 | 3 | $0 | 4 | Chief Legal Officer | 06 Feb 2024, 16:07 |
| PROK | PROKIDNEY CORP. | 16 Jan 2023 | 1 | $0 | 4 | Chief Legal Officer | 18 Jan 2023, 15:11 |
| LGVN | Longeveron Inc. | 21 Dec 2022 | 1 | $0 | 4 | Director | 22 Dec 2022, 17:00 |
| PROK | PROKIDNEY CORP. | 20 Oct 2022 | 1 | $0 | 4 | Chief Legal Officer | 24 Oct 2022, 17:50 |
| PROK | PROKIDNEY CORP. | 11 Jul 2022 | 2 | $0 | 4 | Chief Legal Officer | 13 Jul 2022, 21:29 |
| PROK | PROKIDNEY CORP. | 11 Jul 2022 | 0 | $0 | 3 | Chief Legal Officer | 13 Jul 2022, 21:17 |
| LGVN | Longeveron Inc. | 25 Feb 2022 | 1 | $0 | 4 | Director | 25 Feb 2022, 17:30 |
| LGVN | Longeveron Inc. | 15 Feb 2022 | 0 | $0 | 3 | Director | 22 Feb 2022, 18:45 |
| LSTA | CALADRIUS BIOSCIENCES, INC. | 13 Jan 2022 | 2 | -$3,837 | 4 | CLO, SVP of Corp Dev | 18 Jan 2022, 15:04 |
| LSTA | CALADRIUS BIOSCIENCES, INC. | 10 Jan 2022 | 4 | -$20,045 | 4 | CLO, SVP of Corp Dev | 12 Jan 2022, 15:20 |
| LSTA | CALADRIUS BIOSCIENCES, INC. | 17 Jun 2021 | 0 | $0 | 3 | CLO, SVP of Corp Dev | 08 Nov 2021, 15:58 |